Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans

Journal of Immunology

Volumn 165, Issue 11, 2000, Pages 6463-6471

  Geluk, A ^a   Van Meijgaarden, K E ^a   Franken, K L M C ^a   Drijfhout, J W ^a   D'Souza, S ^a   Necker, A ^a   Huygen, K ^a   Ottenhoff, T H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD8 ANTIGEN; CYTOKINE; DNA VACCINE; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DNA POLYMORPHISM; FLUORESCENCE; HUMAN; IMMUNIZATION; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE;

EID: 0034541180     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.11.6463     Document Type: Article

References (44)

1. Global tuberculosis incidence and mortality during 1990-2000
2. Variation in protection by BCG: Implications of and for heterologous immunity
3. Immunity to intracellular bacteria
4. Identification of HLA class II-restricted determinants of M. tuberculosis-derived proteins using HLA-transgenic, class II deficient mice
5. Regulation of mycobacterial heat-shock protein reactive T cells by HLA class II molecules: Lessons from leprosy
6. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection
7. Differential effects of cytolytic T cell subsets on intracellular infection
8. Vaccination against tuberculosis by DNA injection
9. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
10. Mycobacterial-induced cytotoxic cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients
11. + T cells in vitro
12. + T lymphocytes specific for Mycobacterium tuberculosis
13. CTL response to Mycobacterium tuberculosis: Identification of an immunogenic epitope in the 19-kDa lipoprotein
14. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins
15. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis
16. The antigen 85 complex: A major secreted product of M. tuberculosis
17. Role of the major antigen of Mycobacterium tuberculosis in cell wall biosynthesis
18. T cell mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy
19. Mapping of Th1 helper T cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG
20. HLA class II-associated control of antigen recognition by T cells in leprosy: A prominent role for the 30/31kDa antigens
21. Humoral responses against the 85A and 85B antigens of Mycobacterium bovis BCG in patients with leprosy and tuberculosis
22. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex
23. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex
24. A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide binding motifs
25. A novel, highly efficient peptide-HLA class I binding assay using unfolded heavy chain molecules: Identification of HIV-1 derived peptides that bind to HLA-A*0201 and HLA-A*0301
26. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes
27. Purification of Histagged proteins by immobilized chelate affinity chromatography (IMAC): The benefits from the use of organic solvent
28. Nucleotide sequence of the 85B-protein gene of Mycobacterium bovis BCG and Mycobacterium tuberculosis
29. Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles
30. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability
31. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes
32. Phenotypic analysis of antigen-specific T lymphocytes
33. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes
34. + T cells
35. Adoptive protection of the Mycobacterium tuberculosis-infected lung: Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin
36. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis
37. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice
38. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms
39. + T cells
40. + T cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection
41. Peptide vaccination can lead to enhanced tumor growth through specific T cell tolerance induction
42. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice
43. Severe mycobacterial and salmonella infections in interleukin-12 receptor-deficient patients
44. + T cells requires the production of γ interferon